Literature DB >> 370531

Third Myron Karon Memorial Lecture. Resistance of human tumors to cancer chemotherapeutic agents: an important research problem.

J R Bertino.   

Abstract

The mechanisms whereby malignant cells become biochemically resistant to anti-cancer drugs are surveyed, with emphasis on human tumors. Methotrexate is used as a model to illustrate the mechanisms of resistance that can occur, and how cells can increase their production of dihyrofolate reductase, the target enzyme. Drug resistance remains one of the major impediments to the successful use of chemotherapy for neoplastic diseases.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 370531     DOI: 10.1002/mpo.2950050117

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  4 in total

1.  Saturable process involved in active efflux of vincristine as a mechanism of multidrug resistance in P388 leukemia cells.

Authors:  T Watanabe; M Inaba; Y Sugiyama
Journal:  Pharm Res       Date:  1989-08       Impact factor: 4.200

2.  Cytogenetical changes during early stages of development of methotrexate resistance in HeLa cells.

Authors:  J G Delinassios; M J Talieri
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

3.  The role of methionine in methotrexate-sensitive and methotrexate-resistant mouse leukemia L1210 cells.

Authors:  K J Scanlon; M Kashani-Sabet; A R Cashmore; M Pallai; B A Moroson; M Saketos
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

4.  Methotrexate and methotrexate polyglutamates in human sarcoma metastases after high-dose methotrexate therapy.

Authors:  A Schalhorn; H Sauer; W Wilmanns; G Stupp-Poutot
Journal:  Klin Wochenschr       Date:  1983-11-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.